Shares of IsoRay Inc. (ISR) skyrocketed more than 90% on Wednesday, following an on-line publication of the first major peer reviewed study, which revealed improved results of the company’s Cesium-131 seeds in the treatment of lung cancer.
Forex – financial instrument.Forex news
Shares of IsoRay Inc. (ISR) skyrocketed more than 90% on Wednesday, following an on-line publication of the first major peer reviewed study, which revealed improved results of the company’s Cesium-131 seeds in the treatment of lung cancer.